Development of a compounded propofol nanoemulsion using multiple non-invasive process analytical technologies

Propofol is the preferred anaesthetic for induction and maintenance of sedation in critically ill mechanically ventilated COVID-19 patients. However, during the outbreak of the COVID-19 pandemic, regular supply chains could not keep up with the sudden increase in global demand, causing drug shortage...

Descripción completa

Detalles Bibliográficos
Autores principales: Rooimans, T., Damen, M., Markesteijn, C.M.A., Schuurmans, C.C.L., de Zoete, N.H.C., van Hasselt, P.M., Hennink, W.E., van Nostrum, C.F., Hermes, M., Besseling, R., Vromans, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101488/
https://www.ncbi.nlm.nih.gov/pubmed/37061210
http://dx.doi.org/10.1016/j.ijpharm.2023.122960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101488/
https://www.ncbi.nlm.nih.gov/pubmed/37061210
http://dx.doi.org/10.1016/j.ijpharm.2023.122960

Ejemplares similares